Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components-Reference-Cited by-同舟云学术

Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components

Published:1999-10 Issue:4 Volume:48 Page:543-552
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Eagling ,Profit ,Back

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.1999.00052.x/fullpdf

Reference51 articles.

1. Interaction of citrus juices with felodipine and nifedipine.;Bailey;Lancet,1991

2. Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release formulation.;Bailey;Br J Clin Pharmacol,1995

3. Trough concentrations of cyclosporine in blood following administration with grapefruit juice.;Ducharme;Br J Clin Pharmacol,1993

4. Disposition of oral and intravenous cyclosporin after administration with grapefruit juice.;Ducharme;Clin Pharmacol Ther,1995

5. Interaction between grapefruit juice and midazolam in humans.;Kupferschmidt;Clin Pharmacol Ther,1995

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between grapefruit juice and psychotropic medications: an update of the literature and an original case series;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03

2. Pharmacokinetics of Dasatinib in Rats: a Potential Food–Drug Interaction with Naringenin;European Journal of Drug Metabolism and Pharmacokinetics;2024-02-20

3. Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer;Biomedical Reports;2023-10-04

4. Interaction of Statins with Grapefruit Juice;Fabad Journal of Pharmaceutical Sciences;2023-05-17

5. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients;Acta Pharmaceutica Sinica B;2023-01